MEDRAD¿ Stellant CT Injector System with Certegra Workstation; intended for the specific purp...
FDA Device Recall #Z-1686-2015 — Class II — September 20, 2013
Recall Summary
| Recall Number | Z-1686-2015 |
| Classification | Class II — Moderate risk |
| Date Initiated | September 20, 2013 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Medrad Inc dba Bayer R&I |
| Location | Indianola, PA |
| Product Type | Devices |
| Quantity | 133 |
Product Description
MEDRAD¿ Stellant CT Injector System with Certegra Workstation; intended for the specific purpose of injecting intravenous contrast media into humans for diagnostic studies in computed tomography (CT) applications.
Reason for Recall
The root cause investigation showed that the under-volume hazard can occur when the unit has been configured to prime with contrast, but instead primes with saline due to the configuration data not being sent to the injector head. This may create a non-optimal priming condition that could lead to under-infusion.
Distribution Pattern
Nationwide Distribution
Lot / Code Information
Material numbers: 3032458, 3007301, 3010432 with serial numbers: 10054 37918 37921 36714 36721 108 40596 23834 10065 39533 20092 29884 33423 10026 10028 10032 10035 10069 29881 30351 23741 27877 10095 20693 30548 33316 21089 10123 10008 24272 37177 25989 39003 39009 38894 38894 38840 38843 34894 38833 35824 38846 26107 37073 37472 10058 10010 10076 24707 10091 38400 38403 38404 38405 40390 10093 38999 39434 37351 37359 37358 37367 40225 34619 10127 38989 37298 37461 37462 35172 35173 35175 35176 34630 25348 36811 33443 36432 38007 31538 33315 35434 20178 25804 10280 28893 31196 35454 38011 29248 30219 39034 38940 36975 23511 36937 36966 36086 10030 10027 37839 35554 33020 10212 10145 38631 31620 37996 38906 39201 38659 31537 33314 38895 39049 38930 38319 38995 38996 38678 30429 30540 10064 38322 38196 38197 39509 33230 38831 10107 37431 26933 39171 39191 34829 37684 41169
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.